BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 15293565)

  • 1. Molecular mechanisms of lymphangiogenesis.
    Takahashi M; Yoshimoto T; Kubo H
    Int J Hematol; 2004 Jul; 80(1):29-34. PubMed ID: 15293565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation.
    Saharinen P; Tammela T; Karkkainen MJ; Alitalo K
    Trends Immunol; 2004 Jul; 25(7):387-95. PubMed ID: 15207507
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular targeting of lymphatics for therapy.
    Stacker SA; Hughes RA; Achen MG
    Curr Pharm Des; 2004; 10(1):65-74. PubMed ID: 14754406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lymphangiogenesis].
    Hosono K; Majima M
    Nihon Yakurigaku Zasshi; 2013 May; 141(5):290-1. PubMed ID: 23665561
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.
    Davydova N; Harris NC; Roufail S; Paquet-Fifield S; Ishaq M; Streltsov VA; Williams SP; Karnezis T; Stacker SA; Achen MG
    J Biol Chem; 2016 Dec; 291(53):27265-27278. PubMed ID: 27852824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vascular endothelial growth factor (VEGF)-D in association with VEGF receptor-3 in lymphatic metastasis of breast cancer].
    Chen YN; Gu Y
    Ai Zheng; 2009 Dec; 28(12):1337-43. PubMed ID: 19958632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of lymphangiogenic factors in tumor metastasis.
    He Y; Karpanen T; Alitalo K
    Biochim Biophys Acta; 2004 Mar; 1654(1):3-12. PubMed ID: 14984763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins.
    Karkkainen MJ; Haiko P; Sainio K; Partanen J; Taipale J; Petrova TV; Jeltsch M; Jackson DG; Talikka M; Rauvala H; Betsholtz C; Alitalo K
    Nat Immunol; 2004 Jan; 5(1):74-80. PubMed ID: 14634646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-induced lymphangiogenesis: a target for cancer therapy?
    Thiele W; Sleeman JP
    J Biotechnol; 2006 Jun; 124(1):224-41. PubMed ID: 16497404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lymphangiogenesis and tumor progression].
    Vittet D; Feige JJ
    Bull Cancer; 2007 Oct; 94(10):881-6. PubMed ID: 17964982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting lymphangiogenesis to prevent tumour metastasis.
    Achen MG; Mann GB; Stacker SA
    Br J Cancer; 2006 May; 94(10):1355-60. PubMed ID: 16641900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphangiogenic growth factors, receptors and therapies.
    Lohela M; Saaristo A; Veikkola T; Alitalo K
    Thromb Haemost; 2003 Aug; 90(2):167-84. PubMed ID: 12888864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular control of lymphatic metastasis.
    Achen MG; Stacker SA
    Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Importance of a Proteoglycan Coreceptor in Pathologic Lymphangiogenesis.
    Johns SC; Yin X; Jeltsch M; Bishop JR; Schuksz M; El Ghazal R; Wilcox-Adelman SA; Alitalo K; Fuster MM
    Circ Res; 2016 Jul; 119(2):210-21. PubMed ID: 27225479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study.
    Visuri MT; Honkonen KM; Hartiala P; Tervala TV; Halonen PJ; Junkkari H; Knuutinen N; Ylä-Herttuala S; Alitalo KK; Saarikko AM
    Angiogenesis; 2015 Jul; 18(3):313-26. PubMed ID: 26018927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of VEGF-D and VEGFR-3 in developmental lymphangiogenesis, a chemicogenetic study in Xenopus tadpoles.
    Ny A; Koch M; Vandevelde W; Schneider M; Fischer C; Diez-Juan A; Neven E; Geudens I; Maity S; Moons L; Plaisance S; Lambrechts D; Carmeliet P; Dewerchin M
    Blood; 2008 Sep; 112(5):1740-9. PubMed ID: 18474726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphangiogenesis and lymphatic function in periodontal disease.
    Berggreen E; Wiig H
    J Dent Res; 2013 Dec; 92(12):1074-80. PubMed ID: 24029591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into the molecular control of the lymphatic vascular system and its role in disease.
    Cueni LN; Detmar M
    J Invest Dermatol; 2006 Oct; 126(10):2167-77. PubMed ID: 16983326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of lymphangiogenesis in health and disease.
    Alitalo K; Carmeliet P
    Cancer Cell; 2002 Apr; 1(3):219-27. PubMed ID: 12086857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular mechanisms of lymphatic development].
    Kubo H
    Seikagaku; 2004 Sep; 76(9):1210-6. PubMed ID: 15524110
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.